Department of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco.
Division of Gastroenterology and Hepatology, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
J Clin Gastroenterol. 2020 Jan;54(1):83-89. doi: 10.1097/MCG.0000000000001192.
Gender disparities exist in outcomes among patients with cirrhosis. We sought to evaluate the role of gender on hospital course and in-hospital outcomes in patients with cirrhosis to help better understand these disparities.
We analyzed data from the National Inpatient Sample (NIS), years 2009 to 2013, to identify patients with any diagnosis of cirrhosis. We calculated demographic and clinical characteristics by gender, as well as cirrhosis complications. Our primary outcome was inpatient mortality. We used logistic regression to associate baseline characteristics and cirrhosis complications with inpatient mortality.
Our cohort included 553,017 patients with cirrhosis admitted from 2009 to 2013. Women made up 39% of the cohort; median age was 57 with 66% non-Hispanic white. Women were more likely than men to have noncirrhosis comorbidities, including diabetes and hypertension but were less likely to have most cirrhosis complications, including ascites and variceal bleeding. Women were more likely than men to have acute bacterial infections (34.9% vs. 28.2%; P<0.001), and were less likely than men to die in the hospital on univariable (odds ratio, 0.88; 95% confidence interval, 0.86-0.90; P<0.001) and multivariable (odds ratio, 0.86; 95% confidence interval, 0.83-0.88; P<0.001) analysis.
In patients hospitalized with cirrhosis, women have lower rates of hepatic decompensating events and higher rates of nonhepatic comorbidities and infections, resulting in lower in-hospital mortality. Understanding differences in indications for and disposition following hospitalization may help with the development of gender-specific cirrhosis management programs to improve long-term outcomes in women and men living with cirrhosis.
在肝硬化患者的预后中存在性别差异。我们试图评估性别对肝硬化患者住院过程和院内结局的影响,以帮助更好地理解这些差异。
我们分析了 2009 年至 2013 年国家住院患者样本(NIS)的数据,以确定任何肝硬化诊断的患者。我们按性别计算了人口统计学和临床特征,以及肝硬化并发症。我们的主要结局是住院死亡率。我们使用逻辑回归将基线特征和肝硬化并发症与住院死亡率联系起来。
我们的队列包括 2009 年至 2013 年期间因肝硬化住院的 553,017 名患者。女性占队列的 39%;中位年龄为 57 岁,66%为非西班牙裔白人。与男性相比,女性更有可能患有非肝硬化合并症,包括糖尿病和高血压,但更不可能患有大多数肝硬化并发症,包括腹水和静脉曲张出血。女性更有可能患有急性细菌性感染(34.9%比 28.2%;P<0.001),并且在单变量(优势比,0.88;95%置信区间,0.86-0.90;P<0.001)和多变量(优势比,0.86;95%置信区间,0.83-0.88;P<0.001)分析中,女性更不可能在医院死亡。
在因肝硬化住院的患者中,女性发生肝功能失代偿事件的比率较低,而非肝脏合并症和感染的比率较高,导致住院死亡率较低。了解住院后治疗和出院的差异可能有助于制定针对特定性别的肝硬化管理计划,以改善男女肝硬化患者的长期预后。